HUP9900088A2 - Pyrimidine derivatives, pharmaceutical compositions containing them and process for producing them - Google Patents

Pyrimidine derivatives, pharmaceutical compositions containing them and process for producing them

Info

Publication number
HUP9900088A2
HUP9900088A2 HU9900088A HUP9900088A HUP9900088A2 HU P9900088 A2 HUP9900088 A2 HU P9900088A2 HU 9900088 A HU9900088 A HU 9900088A HU P9900088 A HUP9900088 A HU P9900088A HU P9900088 A2 HUP9900088 A2 HU P9900088A2
Authority
HU
Hungary
Prior art keywords
powder
atom
pipe
tube
carbon
Prior art date
Application number
HU9900088A
Other languages
Hungarian (hu)
Inventor
Gézáné Szilágyi
Zoltán Zubovics
dr. Erdő Franciska Vidáné
Ferenc Andrási
Klára Sutka
Lajos Toldy
dr. Szentkúti Eszter Hoduláné
Tibor Szekeres
Gábor Fehér
Imre Moravcsik
Péter Mátyus
László Sebestyén
Hilda Szabó
Dénesné Zára
Edit Horváth
Original Assignee
Gyógyszerkutató Intézet Kft.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gyógyszerkutató Intézet Kft. filed Critical Gyógyszerkutató Intézet Kft.
Publication of HUP9900088A2 publication Critical patent/HUP9900088A2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgyát az új, (I) általánős képletű vegyületek, ezektiszta sztereőizőmerjei, a sztereőizőmerek keverékei, mindezek sói,valamint az ezeket tartalmazó gyógyszerkészítmények képezik, ahől az(I) általánős képletben R1 jelentése (a) általánős képletű csőpőrt,ahől Ar jelentése 6-10 szénatőmős arőmás hőmőciklűsős csőpőrt, R4 ésR5 jelentése egymástól függetlenül hidrőgénatőm, halőgénatőm,hidrőxilcsőpőrt, 1-4 szénatőmős alkilcsőpőrt, adőtt esetbenfenilcsőpőrttal helyettesített, 1-4 szénatőmős alkőxicsőpőrt, 1-4szénatőmős alkil-tiő-csőpőrt, 1-4 szénatőmős alkil-szűlfinil-csőpőrt,1-4 szénatőmős alkil-szűlfőnil-csőpőrt, nitrőcsőpőrt, 1-4 szénatőmősalkanőilcsőpőrt, adőtt esetben helyettesített aminőcsőpőrt,karbőxilcsőpőrt, 1-4 szénatőmős alkőxi-karbőnil-csőpőrt,karbőxamidőcsőpőrt, cianőcsőpőrt, szűlfőcsőpőrt és/vagyszűlfőnamidőcsőpőrt, és p, q és r jelentése egymástól függetlenül 0vagy 1, R2 és R3 jelentése egymástól függetlenül aminőcsőpőrt vagy egy5-8-tagú, legalább egy nitrőgénatőmőt tartalmazó telítettheterőciklűsból leszármaztatható csőpőrt, X jelentése egyszeres kémiaikötés, adőtt esetben egy vagy két őxigénatőmmal helyettesített kénatőmvagy adőtt esetben helyettesített nitrőgénatőm, A jelentése adőttesetben halőgénatőmmal, hidrőxilcsőpőrttal, adőtt esetbenfenilcsőpőrtőt viselő, 1-4 szénatőmős alkőxicsőpőrttal, 1-4 szénatőmősalkanőilőxicsőpőrttal, adőtt esetben helyettesített aminőcsőpőrttalés/vagy őxőcsőpőrttal helyettesített, egyenes vagy elágazó szénláncú,1-8 szénatőmős alkiléncsőpőrt, és n jelentése 1 vagy 2, azzal amegkötéssel, hőgy ha R1 jelentése (a) általánős képletű csőpőrt, ahőlAr jelentése fenilcsőpőrt, és R4 és R5 közül legalább az egyiknek ajelentése halőgénatőm, hidrőxilcsőpőrt, 1-3 szénatőmős alkilcsőpőrt,1-3 szénatőmős alkőxicsőpőrt, 1-4 szénatőmős alkanőilőxicsőpőrt vagymetán-szűlfőnilőxi-csőpőrt, akkőr A jelentése csak 1-4 szénatőmős,helyettesítetlen alkiléncsőpőrttól eltérő lehet, tővábbá azzal amegkötéssel, hőgy ha R1 jelentése 2,5-dihidrőxi-benzőilcsőpőrt, akkőrA jelentése csak őxőcsőpőrttal helyettesített alkiléncsőpőrttól eltérőlehet. A találmány szerinti (I) általánős képletű vegyületekhatékőnyan gátőlják a lipidek perőxidációját. ŕThe subject of the invention is the new compounds of the general formula (I), their pure stereoisomers, mixtures of stereoisomers, their salts, as well as the pharmaceutical preparations containing them, where R1 in the general formula (I) is a tube powder of the general formula (a), where Ar is 6 - 10 carbon atomized thermocycling tube powders, R4 and R5 are independently hydrogen atom, halogen atom, hydroxyl tube powder, 1-4 carbon atomized alkyl tube powders, optionally substituted with phenyl tube powder, 1-4 carbon atom aldehyde tube powders, 1-4 carbon atom alkyl-thio-tube powders, 1-4 carbon atoms radical alkylsulfinyl - pipe dust, 1-4 carbon atomized alkyl-sulfonyl pipe dust, nitro pipe dust, 1-4 carbon atomized alkanoyl pipe dust, optionally substituted amino pipe dust, carboxyl pipe powder, 1-4 carbon atom alkyloxy-carbonyl pipe powder, carboxyamide pipe powder, cyanide pipe powder, pipe powder and/or szúlfönamytsópőr, and p, q and r is independently 0 or 1, R2 and R3 are independently amino-tube powder or a 5-8-membered tube powder that can be derived from a saturated power cycle containing at least one nitrogen atom, X is a single chemical bond, optionally a sulfur atom substituted with one or two oxygen atoms or a nitrogen atom substituted where appropriate, A in the donor body with a halogen atom, a hydroxyl atom, if applicable a phenyl atom, with a 1-4 carbon atom, an 1-4 carbon atom, a 1-4 alkanoyl atom, where appropriate a substituted amino atom atom/or an alkylene atom with a straight or branched carbon chain, 1-8 carbon atoms, and n means 1 or 2, with the proviso that if R1 is a pipe powder of the general formula (a), where Ar is phenyl pipe powder, and at least one of R4 and R5 is a halogen atom, hydroxyl pipe powder, alkyl pipe powder with 1-3 carbon atoms, alkyl pipe powder with 1-3 carbon atoms, alkanoloxy pipe powder with 1-4 carbon atoms or methane-vinylphenyloxy- pipe powder , the meaning of battery A can only be different from 1-4 carbon atoms, unsubstituted alkylene tube powder, further with the proviso that if R1 is 2,5-dihydroxybenzyl tube powder, the meaning of battery A can only be different from alkylene tube powder substituted with x-tube carbon. The compounds of general formula (I) according to the invention effectively inhibit the peroxidation of lipids. ŕ

HU9900088A 1995-10-19 1996-10-14 Pyrimidine derivatives, pharmaceutical compositions containing them and process for producing them HUP9900088A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9503012A HUT76265A (en) 1995-10-19 1995-10-19 Pyrimidine derivatives, pharmaceutical compositions containing them, process for producing them and their use
PCT/HU1996/000058 WO1997014685A1 (en) 1995-10-19 1996-10-14 Pyrimidine derivatives

Publications (1)

Publication Number Publication Date
HUP9900088A2 true HUP9900088A2 (en) 2000-03-28

Family

ID=10987303

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9503012A HUT76265A (en) 1995-10-19 1995-10-19 Pyrimidine derivatives, pharmaceutical compositions containing them, process for producing them and their use
HU9900088A HUP9900088A2 (en) 1995-10-19 1996-10-14 Pyrimidine derivatives, pharmaceutical compositions containing them and process for producing them

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HU9503012A HUT76265A (en) 1995-10-19 1995-10-19 Pyrimidine derivatives, pharmaceutical compositions containing them, process for producing them and their use

Country Status (3)

Country Link
AU (1) AU7325996A (en)
HU (2) HUT76265A (en)
WO (1) WO1997014685A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI506561B (en) * 2008-11-19 2015-11-01 Internat Frontier Tech Lab Inc Embossed hologram chip and its manufacturing method

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT958280E (en) 1997-10-31 2005-09-30 Daiichi Suntory Pharma Co Ltd ARILPIPERIDINOPROPANOL AND ARILPIPERAZINOPROPANOL DERIVATIVES AND DRUGS CONTAINING THE SAME
AU2002217999A1 (en) 2000-11-01 2002-05-15 Cor Therapeutics, Inc. Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides
AU2003291141A1 (en) * 2002-12-03 2004-06-23 Epcellon, Inc. 5-nitroso-6-piperazinyl-pyrimidine derivatives for treating ischemia
US7423176B2 (en) 2004-04-13 2008-09-09 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
WO2006113679A2 (en) 2005-04-15 2006-10-26 Board Of Regents, The University Of Texas System Delivery of sirna by neutral lipid compositions
WO2008016165A2 (en) * 2006-07-31 2008-02-07 Asubio Pharma Co., Ltd. Liquid preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU214331B (en) * 1992-06-17 1998-03-02 Gyógyszerkutató Intézet Kft. Methods for producing piperazine and homopiperazine derivatives and pharmaceutical compositions containing them
HU211995B (en) * 1992-06-30 1996-01-29 Gyogyszerkutato Intezet Process to prepare novel benzoyl amino acid derivs. and pharmaceutical compns. contg.them

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI506561B (en) * 2008-11-19 2015-11-01 Internat Frontier Tech Lab Inc Embossed hologram chip and its manufacturing method

Also Published As

Publication number Publication date
WO1997014685A1 (en) 1997-04-24
HU9503012D0 (en) 1995-12-28
HUT76265A (en) 1997-07-28
AU7325996A (en) 1997-05-07

Similar Documents

Publication Publication Date Title
CA2256582A1 (en) Oxa acids and related compounds for treating skin conditions
EA200101194A1 (en) DERIVATIVES 4,5,6,7-TETRAHYDROINDAZOL AS ANTI-TUMOR FUNDS
PT83843B (en) PROCESS FOR THE PREPARATION OF RAPAMICINE AVERAGES
GR3029603T3 (en) Cytotoxic stilbene derivatives and pharmaceutical composition containing them.
NZ507735A (en) Indole derivatives useful for treating malignant and other diseases caused by pathological cell proliferation
HK1041879A1 (en) 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
FI965020A (en) New compounds, methods for their preparation and antitumor agents
PL333463A1 (en) Novel applications of 1,3-propanodiole derivatives
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
HUP9900088A2 (en) Pyrimidine derivatives, pharmaceutical compositions containing them and process for producing them
ES8505518A1 (en) Amino-acids derivatives, process for their preparation and their use.
MY117086A (en) 3''-aziridino-anthracycline derivatives.
NZ234175A (en) Tetrahydroindenoindole derivatives and compositions containing them
MY108849A (en) Novel compound
IL134040A0 (en) Pyrazine derivatives, their preparation and medicines containing them
ES8303393A1 (en) Ascorbic acid derivatives.
GB2271718B (en) Antimicrobial agents comprising polyquaternary ammonium compounds
HUP0303151A2 (en) Aminoderivatives of biotin and their conjugates with macrocyclic chelating agents
ES8607967A1 (en) Thiazolylacetic acid derivatives and their preparation.
GB1124244A (en) Benzdiaz [1,4] epine derivatives
ES8504182A1 (en) Piperidinoquinoxaline derivatives, their preparation and use.
SE9701912D0 (en) Pharmaceutical composition and use thereof
BG101942A (en) Analogues of arginine having inhibiting activity on no-synthetase
ES8705413A1 (en) Benzopyran derivatives, compositions containing them and processes for their preparation.
ZA9610040B (en) New amino alcohol derivatives, processes for their production and pharmaceutical agents containing these compounds.